86 related articles for article (PubMed ID: 2069296)
1. Role of interleukin-4 in the negative regulation of proliferation of chronic myelomonocytic leukemia cells.
Harada M; Akashi K; Shibuya T; Takamatsu Y; Niho Y
Ann N Y Acad Sci; 1991; 628():156-64. PubMed ID: 2069296
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.
Akashi K; Shibuya T; Harada M; Takamatsu Y; Uike N; Eto T; Niho Y
J Clin Invest; 1991 Jul; 88(1):223-30. PubMed ID: 2056118
[TBL] [Abstract][Full Text] [Related]
3. IL-4 stimulates the growth of chronic myelomonocytic leukemia cells (CMMoL) once leukemic transformation has occurred.
Yanagisawa K; Hatta N; Watanabe I; Horiuchi T; Hasegawa H; Fujita S
Leukemia; 1995 Jun; 9(6):1056-9. PubMed ID: 7596169
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells.
Everson MP; Brown CB; Lilly MB
Blood; 1989 Oct; 74(5):1472-6. PubMed ID: 2676012
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-4 in chronic myelomonocytic leukemia. Growth suppression of hematopoietic precursors in the chronic phase and stimulation in the acute phase.
Yanagisawa K; Kishimoto K; Horiuchi T; Takada K; Yasukawa M; Fujita S
Acta Haematol; 1994; 92(2):104-8. PubMed ID: 7817702
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells.
Geissler K; Ohler L; Födinger M; Virgolini I; Leimer M; Kabrna E; Kollars M; Skoupy S; Bohle B; Rogy M; Lechner K
J Exp Med; 1996 Oct; 184(4):1377-84. PubMed ID: 8879210
[TBL] [Abstract][Full Text] [Related]
7. Enhancement by transforming growth factor-beta 1 (TGF-beta 1) of the proliferation of leukemic blast progenitors stimulated with IL-3.
Suzuki T; Bessho M; Hirashima K; Tohda S; Nagata K; Morio T; Imai Y; Nara N
J Cell Physiol; 1991 Sep; 148(3):396-403. PubMed ID: 1717497
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin 1: a potential anti-leukemic agent for chronic myelomonocytic leukemia.
Lilly M; Brown C; Pettit G; Kraft A
Leukemia; 1991 Apr; 5(4):283-7. PubMed ID: 2027297
[TBL] [Abstract][Full Text] [Related]
9. Suppression of chronic myelogenous leukemia colony growth by interleukin-4.
Estrov Z; Markowitz AB; Kurzrock R; Wetzler M; Kantarjian HM; Ferrajoli A; Gutterman JU; Talpaz M
Leukemia; 1993 Feb; 7(2):214-20. PubMed ID: 8426475
[TBL] [Abstract][Full Text] [Related]
10. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
[TBL] [Abstract][Full Text] [Related]
11. Divergent effects of IL-10 and IL-4 on the proliferation and growth factor secretion by acute myeloblastic leukemic cells.
Tuyt LM; Dokter WH; Esselink MT; Vellenga E
Eur Cytokine Netw; 1995; 6(4):231-5. PubMed ID: 8789288
[TBL] [Abstract][Full Text] [Related]
12. The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells.
Wagteveld AJ; Esselink MT; Limburg P; Halie MR; Vellenga E
Leukemia; 1992 Oct; 6(10):1020-4. PubMed ID: 1405754
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
14. In vitro differentiation and proliferation of human hematopoietic progenitors: the effects of interleukins 1 and 6 are indirectly mediated by production of granulocyte-macrophage colony-stimulating factor and interleukin 3.
Migliaccio G; Migliaccio AR; Adamson JW
Exp Hematol; 1991 Jan; 19(1):3-10. PubMed ID: 1989893
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension culture.
Miyauchi J; Clark SC; Tsunematsu Y; Shimizu K; Park JW; Ogawa T; Toyama K
Leukemia; 1991 Feb; 5(2):108-15. PubMed ID: 1708433
[TBL] [Abstract][Full Text] [Related]
16. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor and interleukin 4 induce differentiation in the U-937 human monocytic leukemia cell line.
Koss A; Lucero G; Koziner B
Leuk Lymphoma; 1996 Jun; 22(1-2):163-71,follow.186,color plate XIV-V. PubMed ID: 8724544
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 4, but not interleukin 10, regulates the production of inflammation mediators by rheumatoid synoviocytes.
Dechanet J; Rissoan MC; Banchereau J; Miossec P
Cytokine; 1995 Feb; 7(2):176-83. PubMed ID: 7780037
[TBL] [Abstract][Full Text] [Related]
19. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
[TBL] [Abstract][Full Text] [Related]
20. Deoxyribonucleic acid triplex formation inhibits granulocyte macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.
Kochetkova M; Iversen PO; Lopez AF; Shannon MF
J Clin Invest; 1997 Jun; 99(12):3000-8. PubMed ID: 9185524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
